Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

63%

5 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 3

4(50.0%)

Phase 1

1(12.5%)

Early Phase 1

1(12.5%)

Phase 4

1(12.5%)

N/A

1(12.5%)

8Total

Phase 3(4)

Phase 1(1)

Early Phase 1(1)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07298057Early Phase 1Recruiting

Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics

Role: collaborator

NCT00639860Phase 1Completed

Evaluation of OSSIX-Plus Resorbable Collagen Membranes for Alveolar Ridge Preservation Following Exodontia

Role: collaborator

NCT01517334Phase 3Completed

Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)

Role: lead

NCT01539564Phase 3Completed

Arestin - Use in Subjects With Peri-Implantitis

Role: lead

NCT00937976Not ApplicableCompleted

Treatment for Periodontal Disease in Dialysis Patients

Role: collaborator

NCT00662532Phase 3Completed

Antibiotic Study for Dental Implants

Role: lead

NCT00668746Phase 4Completed

Long-term Safety of Minocycline in Patients With Gum Disease

Role: lead

NCT00371332Phase 3Completed

Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis

Role: lead

All 8 trials loaded